Director, Access Strategy Marketing NSCLC

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The Director, Access Strategy & Marketing will lead the development and execution of access strategy, value proposition development, and execution of marketing materials for the RevMed NSCLC portfolio.

Requirements

• Developing and aligning with cross-functional partners on the three-year access strategy across RevMed’s NSCLC portfolio.
• Lead the creation of value proposition messaging and materials tailored for payers, PBMs, IDNs, GPOs, channel partners, and other key managed care decision-makers.
• Partner with national account field team to educate on access strategy and available resources.